"

Healthcare Founder Toolkit

"
 
Talk to Us
PHARMAPRO
Write An Impactful Investor Update
A practical guide for healthcare founders on how to write investor updates that build trust, maintain credibility, and keep your investors calibrated — even when the numbers are mixed.
Read More

Core Principle:

Investor updates should read like a briefing, not a newsletter. Lead with numbers, explain what changed, state what matters, flag what is off track, and end with a few precise asks. The narrative should support the metrics, not bury them.

Sam Altman's test
"The most predictive part of a startup's investor update is the ratio of numbers to letters."
Style Rules
Do
  • Write tight, factual, and skimmable
  • Show actual vs. plan for every key metric
  • Use short paragraphs and crisp bullet points
  • Add the most decision-relevant information first
Avoid
  • "Heads down building"
  • Reporting % of goal completion without stating the goal
  • "Making great progress" or "lots of momentum"
  • Skipping the "What's Not Working" section
Recommended Structure
  • Subject line: [Company] Investor Update | [Month Year]

Section 1: Snapshot (30 Seconds)

Start with the reporting period and the handful of numbers an investor should know in under 30 seconds. Always show actual versus plan — investors track the gap, not just the absolute number.

Section 2: TL;DR Narrative

Write 3–5 sentences in your own voice. This paragraph does the heavy lifting — everything below it is detail for investors who want to dig in. It must answer five questions:

Five questions your TL;DR must answer
  • What was the biggest win or miss this month?
  • What is the key strategic or product move?
  • What is the team headline?
  • What is the one honest flag — burn, pipeline gap, a risk?
  • What is the team's energy and direction right now?
“
Example:
We closed April at ₹18.2 mn GMV, 94% of plan, driven by Tier-2 expansion and TPA empanelment with 2 insurers covering 3.2 lakh lives. The strategic bet this month was shifting our product bandwidth toward B2B corporate wellness. Burn was elevated at ₹3.1 mn due to onboarding costs; Q2 pipeline coverage is at 1.2x against a ₹22 mn target — both areas we are actively managing. The team is executing well.
*Note: The company strategy section must be in your own words. Investors can tell when a founder did not write their own conviction.

Section 3: What Changed

Use 2–4 bullets. Each bullet should contain one clear development and at least one number.

Examples
  • GMV rose to ₹18.2 mn from ₹15.1 mn, driven by a 22% increase in repeat orders and expansion into 4 new Tier-2 cities.
  • We signed distribution agreements with 3 regional pharmacy chains (120 stores total) in Gujarat and Maharashtra, bringing total retail touchpoints to 340.
  • Gross burn fell 11% month over month after renegotiating cloud hosting and consolidating CRM tools.

Section 4a: What's Working

This section is about proof points, not optimism. Keep it to 2–3 bullets and anchor every claim to a metric.

Examples
  • Our telehealth platform completed 1,420 consultations in April vs. 980 in March, with average wait time down to 8 minutes from 14 minutes.
  • B2B pilot with a corporate wellness client (12,000 employees) went live on May 1 and recorded 340 health assessments in the first week, 18% ahead of plan.
  • We secured empanelment with 2 TPAs covering 3.2 lakh lives, with claims processing live from June 1.

Section 4b: Customer Evidence

One specific customer quote, outcome data point, or provider testimonial anchors your narrative in real-world impact. In healthcare, clinical outcomes drive enterprise procurement. A single credible proof point here often does more for investor confidence than an additional metrics row.

Example:

A corporate wellness client reported a 23% reduction in absenteeism over 90 days, which they attributed directly to the platform's preventive screening programme. The VP of HR has agreed to serve as a reference for our next enterprise sale cycle.

Section 5: What's Not working

Be candid. Investors tolerate bad news more than delayed news. Before finalising, verify you have named: elevated burn (and why), tight pipeline coverage (and what you are doing), any churn with the actual reason, and runway if under 18 months. Use the format:


Problem → Hypothesis → What We Are Testing

Examples
  • Lost 2 hospital tie-up opportunities; ₹1,200 per patient per month was cited as the blocker in both cases. Hypothesis: hospitals want outcome-linked pricing. Testing: tiered model at ₹600 base + ₹50 per engagement.
  • Doctor onboarding dropped 30% versus plan. Hypothesis: 7-day verification causes drop-offs. Testing: instant provisional onboarding with post-verification for low-risk specialties.
  • ABDM integration milestone slipped 3 weeks due to sandbox API changes. Brought in ABDM-certified integration partner; reset go-live to June 22.

Section 6: Asks

Limit this to one or two asks. Each ask should be specific enough that an investor can act on it in under five minutes.

Good Asks
  • Introduction to the Head of HR Benefits at a 10,000+ employee company (IT, BFSI, or manufacturing), evaluating corporate wellness platforms.
  • Introduction to a growth-stage healthtech CFO who has navigated TPA contracting and claims reconciliation at scale.
Weak Asks
  • "Any Introductions to corporate clients or health insurance folks would be helpful."
  • "Let us know if you can connect us to anyone in pharma."

Section 7: Upcoming Milestones

Close with the next few milestones and dates. This helps investors track execution without guessing what matters next.

Format:
  • Product: [feature launch or integration milestone] — [date]
  • Commercial: [partnership, pilot, or sales milestone] — [date]
  • Compliance: [certification, audit, or regulatory milestone] — [date]
  • Financing / Hiring: [fundraising close or key hire start date] — [date]
Healthcare Specific Additions
  • Adjust metrics to reflect your business model and What Changed sections to reflect your business model. Generic SaaS metrics signal to healthcare investors that the founder hasn't internalised the sector's key drivers.

Digital Health/Telehealth Platforms

  • User Metrics
    • Monthly active users, consultations completed, repeat consultation rate, average wait time, doctor utilization rate.
  • Commercial Traction
    • B2B pilots (corporates, hospital networks), TPA empanelment, insurance tie-ups, pharmacy partnerships.
  • Compliance
    • ABDM integration milestones, data localization status, ISO 27001 progress, telemedicine guidelines adherence.

Pharmacy/Distribution/Supply Chain

  • GMV and SKU Breadth
    • Gross merchandise value, number of SKUs, order frequency, average basket size, fill rate.
  • Distribution Reach
    • Number of touchpoints (stores, pin codes, dark stores), delivery TAT, serviceable area coverage.
  • Unit Economics
    • Contribution margin per order, customer acquisition cost, repeat purchase rate within 30/60/90 days.

SaaS/Hospital-Tech/Practice Management

  • SaaS Metrics
    • ARR, logo count, net revenue retention, average contract value, seats deployed.
  • Product Adoption
    • Daily active facilities, transactions processed, integrations live (EHR, billing, lab systems).
  • Enterprise Sales
    • Pipeline value, deal cycle length, upsell/cross-sell revenue.

Pre-revenue or Pilot Stage?

  • Lead With The Strongest Leading Indicators
    Signed LOIs, pilot programs launched, users onboarded, provider partnerships signed, demo-to-contract conversion rate, or waitlist size.
Final Template
  • Sub: [Company] Investor Update | [Month Year]


    Hi all — here is our update for [Month Year].

Snapshot

  • Revenue / GMV: ₹[X] mn ARR / MRR
  • vs. Plan: ₹[X] mn target | [Z%] to goal
  • Burn: ₹[X] mn/month
  • Runway: [X] months
  • Pipeline: ₹[X] mn across [Y] active deals
  • Core metric: [X] (up/down [Y]%)
  • Growth: [X]% MoM
  • Regulatory / Compliance: [Key milestone or flag] — [Status]

What Changed

  • [Specific development with number]
  • [Specific development with number]
  • [Specific development with number]

TL;DR Narrative

  • [3–5 sentences answering: biggest win/miss, key strategic move, team headline, one honest flag, team energy]

What's Working

  • [Proof point with number]
  • [Proof point with number]
  • Customer Evidence (optional): [One specific quote, outcome data, or provider testimonial]

What's Not Working

  • [Problem] → [Hypothesis] → [What we are testing]
  • [Problem] → [Hypothesis] → [What we are testing]

Asks

  • [Precise intro / decision / resource needed - forwardable in under 5 minutes]
  • [Optional second ask]

Upcoming Milestones

  • [Milestone] — [Date]
  • [Milestone] — [Date]
  • [Milestone] — [Date]
Editing Checklist
Before sending, confirm the draft does all of the following:
  • Opens with numbers, not scene-setting
  • Shows actual vs. plan with % to goal
  • TL;DR answers all five questions in 3–5 sentences
  • Includes at least one growth or traction metric relevant to your business model
  • States one core metric clearly
  • Includes no more than 2 asks, each specific and forwardable